The Advisory Committee on Immunization Practices (ACIP) recommends that adolescents routinely receive 1 dose of
tetanus toxoid, reduced
diphtheria toxoid, and acellular
pertussis (Tdap)
vaccine, 2 doses of meningococcal conjugate (
MenACWY)
vaccine, and 3 doses of human papillomavirus (HPV)
vaccine.* ACIP also recommends administration of "catch-up"† vaccinations, such as
measles,
mumps, and
rubella (MMR),
hepatitis B, and
varicella, and, for all persons aged ≥6 months, an annual
influenza vaccination. ACIP recommends administration of all age-appropriate
vaccines during a single visit. To assess vaccination coverage among adolescents aged 13-17 years, CDC analyzed data from the 2013 National Immunization Survey-Teen (NIS-Teen).§ This report summarizes the results of that analysis, which show that from 2012 to 2013, coverage increased for each of the
vaccines routinely recommended for adolescents: from 84.6% to 86.0% for ≥1 Tdap dose; from 74.0% to 77.8% for ≥1
MenACWY dose; from 53.8% to 57.3% for ≥1 HPV dose among females, and from 20.8% to 34.6% for ≥1 HPV dose among males. Coverage varied by state and local jurisdictions and by U.S. Department of Health and Human Services (HHS) region. Healthy People 2020 vaccination targets for adolescents aged 13-15 years were reached in 42 states for ≥1 Tdap dose, 18 for ≥1
MenACWY dose, and 11 for ≥2
varicella doses. No state met the target for ≥3 HPV doses.¶ Use of patient reminder and recall systems, immunization information systems, coverage assessment and feedback to clinicians, clinician reminders,
standing orders, and other interventions can help make use of every health care visit to ensure that adolescents are fully protected from
vaccine-preventable
infections and
cancers (5), especially when such interventions are coupled with clinicians' vaccination recommendations.